CDKN2A and melanoma: The spectrum of tumors in relatives diagnosed with cancer in the families of six CDKN2A mutation carriers included melanoma (7×), breast cancer (3×), rectal cancer (2×), and gastric, pancreatic, lung, and endometrial cancer, brain tumor, and leukemia (one each).